AFP and neoplasm: Tumour burden at presentation was similar, but PWH had a higher proportion of advanced BCLC‐C stage (22% vs. 10%, p < 0.001), more frequent MVI and/or EHS (27% vs. 11%, p < 0.001), and elevated AFP > 200 ng/mL (28% vs. 15%, p = 0.001).